Abstract
Background: Systemic adenoviral readministration appears to be limited by immunogenicity. Aims: We examined the feasibility of repeated adenovirus mediated gene transfer into the liver via the biliary tract. Methods: Recombinant...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have